IP Library › Assignment 058308/0804
Patent Assignment
Reel/Frame 058308/0804

Assignment of Assignor's Interest

Recorded: 2021-12-06 Pages: 3
Assignors
TIAN, WENZHI
Executed: 2021-11-25
LI, SONG
Executed: 2021-11-25
CHEN, DIANZE
Executed: 2021-11-25
Assignee
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) CO., LTD.
BUILDING #15, LANE 1000, ZHANGHENG ROAD, PUDONG NEW DISTRICT, SHANGHAI, 201203, CHINA
Covered Property (1)
Recombinant Fusion Proteins Targeting CD47 and CD24, Preparation and Use Thereof
Application: 17/543,033 →
Publication: US 2023/0114491
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Jul 6, 2022
From: IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) CO., LTD.
To: IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.
Reel/Frame 060594/0209 →